EKF Diagnostics Holdings Plc (EKF) - Net Assets

Latest as of December 2025: GBX70.28 Million GBX ≈ $8.55K USD

Based on the latest financial reports, EKF Diagnostics Holdings Plc (EKF) has net assets worth GBX70.28 Million GBX (≈ $8.55K USD) as of December 2025. Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (GBX81.14 Million ≈ $9.87K USD) and total liabilities (GBX10.86 Million ≈ $1.32K USD). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off. Check EKF goodwill-adjusted equity ratio to evaluate the tangible quality of the company's equity base.

Key Net Assets Metrics

Metric Value
Current Net Assets GBX70.28 Million
% of Total Assets 86.61%
Annual Growth Rate 27.31%
5-Year Change -25.82%
10-Year Change 15.26%
Growth Volatility 260.65

EKF Diagnostics Holdings Plc - Net Assets Trend (2001–2025)

This chart illustrates how EKF Diagnostics Holdings Plc's net assets have evolved over time, based on quarterly financial data. See EKF defensive interval ratio to measure how many days the company can operate on defensive assets alone.

Annual Net Assets for EKF Diagnostics Holdings Plc (2001–2025)

The table below shows the annual net assets of EKF Diagnostics Holdings Plc from 2001 to 2025. For live valuation and market cap data, see EKF Diagnostics Holdings Plc (EKF) market capitalisation.

Year Net Assets Change
2025-12-31 GBX70.28 Million
≈ $8.55K		 -4.01%
2024-12-31 GBX73.21 Million
≈ $8.91K		 +7.32%
2023-12-31 GBX68.22 Million
≈ $8.30K		 -8.46%
2022-12-31 GBX74.52 Million
≈ $9.07K		 -21.34%
2021-12-31 GBX94.74 Million
≈ $11.53K		 +21.15%
2020-12-31 GBX78.20 Million
≈ $9.51K		 +9.87%
2019-12-31 GBX71.17 Million
≈ $8.66K		 +11.37%
2018-12-31 GBX63.90 Million
≈ $7.78K		 +5.63%
2017-12-31 GBX60.50 Million
≈ $7.36K		 -0.78%
2016-12-31 GBX60.97 Million
≈ $7.42K		 +30.41%
2015-12-31 GBX46.75 Million
≈ $5.69K		 -46.49%
2014-12-31 GBX87.38 Million
≈ $10.63K		 +113.52%
2013-12-31 GBX40.92 Million
≈ $4.98K		 +3.79%
2012-12-31 GBX39.43 Million
≈ $4.80K		 +5.34%
2011-12-31 GBX37.43 Million
≈ $4.55K		 +59.07%
2010-12-31 GBX23.53 Million
≈ $2.86K		 +318.67%
2009-12-31 GBX5.62 Million
≈ $683.79		 +10.85%
2008-12-31 GBX5.07 Million
≈ $616.87		 +1.89%
2007-12-31 GBX4.98 Million
≈ $605.44		 +15.75%
2006-12-31 GBX4.30 Million
≈ $523.06		 +15.75%
2005-12-31 GBX3.71 Million
≈ $451.89		 +19.23%
2004-12-31 GBX3.12 Million
≈ $379.01		 +26.73%
2003-12-31 GBX2.46 Million
≈ $299.07		 +181.18%
2003-06-30 GBX-3.03 Million
≈ $-368.42		 -204.34%
2002-12-31 GBX2.90 Million
≈ $353.09		 +1256.07%
2001-12-31 GBX214.00K
≈ $26.04		 --

Equity Component Analysis

This analysis shows how different components contribute to EKF Diagnostics Holdings Plc's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.

Equity Composition Insights

  • Retained earnings have grown by 30041.0% over the analyzed period, indicating profitable operations and earnings retention.

Current Equity Component Breakdown (December 2025)

Component Amount Percentage
Retained Earnings GBX52.14 Million 75.52%
Common Stock GBX4.34 Million 6.28%
Other Comprehensive Income GBX5.12 Million 7.42%
Other Components GBX7.44 Million 10.78%
Total Equity GBX69.05 Million 100.00%

EKF Diagnostics Holdings Plc Competitors by Market Cap

The table below lists competitors of EKF Diagnostics Holdings Plc ranked by their market capitalization.

Company Market Cap
Niraj Ispat Industries Limited
NSE:NIRAJISPAT
 $1.36 Million
Fuse Cobalt Inc
V:FUSE
 $1.36 Million
Luminar Technologies Inc. Class A
NASDAQ:LAZRQ
 $1.36 Million
Smartfren Telecom Tbk
JK:FREN
 $1.36 Million
GCP Asset Backed Income Fund Limited
LSE:GABI
 $1.36 Million
Aptitude Software Group PLC
LSE:APTD
 $1.35 Million
GlucoTrack Inc
NASDAQ:GCTK
 $1.35 Million
Polledo S.A.
BA:POLL
 $1.35 Million

Equity Growth Attribution

This analysis shows how different factors contributed to changes in EKF Diagnostics Holdings Plc's equity between the two most recent reporting periods.

Equity Growth Insights

  • From 2024 to 2025, total equity changed from 72,327,000 to 69,050,000, a change of -3,277,000 (-4.5%).
  • Net income of 2,122,000 contributed positively to equity growth.
  • Share repurchases of 4,991,000 reduced equity.
  • Other comprehensive income decreased equity by 280,000.

Equity Change Factors (2024 to 2025)

Factor Impact Contribution
Net Income GBX2.12 Million +3.07%
Share Repurchases GBX4.99 Million -7.23%
Other Comprehensive Income GBX-280.00K -0.41%
Other Changes GBX-128.00K -0.19%
Total Change GBX- -4.53%

Book Value vs Market Value Analysis

This analysis compares EKF Diagnostics Holdings Plc's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.

Valuation Insights

  • Current price-to-book ratio: 168.22x
  • The company is trading at a significant premium to its book value, suggesting the market values its earnings potential, brand, or other intangibles highly.
  • The price-to-book ratio has decreased from 17791.12x to 168.22x over the analyzed period, indicating reduced market premium.

Historical Price-to-Book Ratios

Date Book Value per Share Market Price P/B Ratio
2001-12-31 GBX0.00 GBX25.90 x
2002-12-31 GBX0.03 GBX25.90 x
2003-12-31 GBX0.09 GBX25.90 x
2004-12-31 GBX0.09 GBX25.90 x
2005-12-31 GBX0.11 GBX25.90 x
2006-12-31 GBX0.13 GBX25.90 x
2007-12-31 GBX0.15 GBX25.90 x
2008-12-31 GBX0.15 GBX25.90 x
2009-12-31 GBX0.16 GBX25.90 x
2010-12-31 GBX0.24 GBX25.90 x
2011-12-31 GBX0.17 GBX25.90 x
2012-12-31 GBX0.14 GBX25.90 x
2013-12-31 GBX0.14 GBX25.90 x
2014-12-31 GBX0.22 GBX25.90 x
2015-12-31 GBX0.11 GBX25.90 x
2016-12-31 GBX0.13 GBX25.90 x
2017-12-31 GBX0.13 GBX25.90 x
2018-12-31 GBX0.14 GBX25.90 x
2019-12-31 GBX0.15 GBX25.90 x
2020-12-31 GBX0.17 GBX25.90 x
2021-12-31 GBX0.20 GBX25.90 x
2022-12-31 GBX0.16 GBX25.90 x
2023-12-31 GBX0.15 GBX25.90 x
2024-12-31 GBX0.16 GBX25.90 x
2025-12-31 GBX0.15 GBX25.90 x

Capital Efficiency Dashboard

This dashboard shows how efficiently EKF Diagnostics Holdings Plc utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.

Capital Efficiency Insights

  • Current Return on Equity (ROE): 3.07%
  • The company may be facing challenges in efficiently utilizing shareholder equity.
  • DuPont Analysis Breakdown:
  • • Net Profit Margin: 4.12%
  • • Asset Turnover: 0.64x
  • • Equity Multiplier: 1.18x
  • Recent ROE (3.07%) is above the historical average (2.79%), indicating improving capital efficiency.

Historical Capital Efficiency Metrics

Year Return on Equity Net Profit Margin Asset Turnover Equity Multiplier Economic Value Added
2001 137.38% 26.82% 0.20x 25.46x GBX272.60K
2002 4.93% 8.85% 0.25x 2.22x GBX-147.20K
2003 -19.32% -37.25% 0.20x 2.57x GBX-720.80K
2004 -18.91% -26.35% 0.34x 2.14x GBX-900.50K
2005 20.81% 23.70% 0.67x 1.30x GBX401.60K
2006 13.86% 19.37% 0.60x 1.20x GBX166.10K
2007 9.34% 136.36% 0.06x 1.12x GBX-32.60K
2008 -25.78% -281.08% 0.08x 1.13x GBX-1.81 Million
2009 -3.61% -79.30% 0.04x 1.14x GBX-765.00K
2010 -14.79% -52.98% 0.18x 1.55x GBX-5.76 Million
2011 -7.79% -13.32% 0.37x 1.59x GBX-6.59 Million
2012 4.70% 7.02% 0.47x 1.43x GBX-2.06 Million
2013 -2.79% -3.54% 0.52x 1.50x GBX-5.17 Million
2014 -6.54% -14.20% 0.30x 1.56x GBX-14.39 Million
2015 -79.85% -123.56% 0.42x 1.55x GBX-41.77 Million
2016 -0.03% -0.05% 0.47x 1.36x GBX-6.06 Million
2017 4.53% 6.53% 0.54x 1.29x GBX-3.28 Million
2018 15.91% 23.76% 0.52x 1.28x GBX3.76 Million
2019 5.21% 8.19% 0.52x 1.23x GBX-3.38 Million
2020 14.31% 17.03% 0.64x 1.30x GBX3.35 Million
2021 16.84% 19.37% 0.71x 1.22x GBX6.44 Million
2022 -13.77% -15.16% 0.75x 1.22x GBX-17.44 Million
2023 3.50% 4.47% 0.65x 1.20x GBX-4.36 Million
2024 8.63% 12.44% 0.61x 1.13x GBX-990.70K
2025 3.07% 4.12% 0.64x 1.18x GBX-4.78 Million

Industry Comparison

This section compares EKF Diagnostics Holdings Plc's net assets metrics with peer companies in the Medical Devices industry.

Industry Context

  • Industry: Medical Devices
  • Average net assets among peers: $359,765,428
  • Average return on equity (ROE) among peers: -85.07%

Peer Company Comparison

Company Net Assets Return on Equity Debt-to-Equity Market Cap
EKF Diagnostics Holdings Plc (EKF) GBX70.28 Million 137.38% 0.15x $1.36 Million
AOTI Inc (AOTI) $3.41 Million -82.17% 1.74x $813.33K
Creo Medical Group PLC (CREO) $-12.00K 0.00% 0.00x $683.79K
Inspiration Healthcare Group PLC (IHC) $3.12 Million 9.98% 1.06x $245.46K
NIOX Group PLC (NIOX) $81.90 Million 19.66% 0.20x $2.95 Million
Polarean Imaging Plc (POLX) $8.73 Million -75.05% 0.25x $11.75K
Rua Life Sciences PLC (RUA) $6.91 Million -569.75% 0.34x $147.24K
Smith & Nephew PLC (SN) $2.77 Billion 22.18% 0.71x $116.19 Million
Surgical Innovations Group plc (SUN) $1.06 Million -5.40% 0.59x $53.91K

About EKF Diagnostics Holdings Plc

LSE:EKF UK Medical Devices
Market Cap
$1.36 Million
GBX11.15 Billion GBX
Market Cap Rank
#30299 Global
#754 in UK
Share Price
GBX25.90
Change (1 day)
-3.36%
52-Week Range
GBX21.80 - GBX31.90
All Time High
GBX78.21
Categories
Companies in UK Medical Devices
About

EKF Diagnostics Holdings plc engages in the design, development, manufacture, and sale of diagnostic instruments, reagents, and other ancillary products in the Americas, Europe, the Middle East, Asia, Africa, and internationally. The company offers DiaSpect Tm analyzer; Hemo Control, a hemoglobin analyzer; and HemataStat II, a microhematocrit centrifuge that provides a quantitative hematocrit rea… Read more